Pain, placebo, and test of treatment efficacy: a narrative review by Vase, L, Wartolowska, K

Neuromodulation by Kjær, S, Rice, A, Wartolowska, K, Vase, L

Reply to Banik by Kjær, SW, Rice, ASC, Wartolowska, K, Vase, L

The importance of using placebo controls in nonpharmacological randomised trials by Wartolowska, KA, Hohenschurz-Schmidt, D, Vase, L, Aronson, JK

Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management thera... by Hohenschurz-Schmidt, D, Vase, L, Scott, W, Wartolowska, K

Expectations and positive emotional feelings accompany reductions in ongoing and evoked neuropathic pain following placebo interventions. by Petersen, G, Finnerup, N, Grosen, K, Pilegaard, H, Tracey, I, Benedetti, F, Price, D, Jensen, T, Vase, L

Implications of placebo and nocebo effects for clinical practice: expert consensus by Evers, A, Colloca, L, Blease, C, Annoni, M, Atlas, L, Benedetti, F, Bingel, U, Büchel, C, Carvalho, C, Colagiuri, B, Crum, A, Enck, P, Gaab, J, Geers, A, Howick, J, Jensen, K, Kirsch, I, Meissner, K, Napadow, V, Peerdeman, K, Raz, A, Rief, W, Vase, L, Wager, T, Wampold, B, Weimer, K, Wiech, K, Kaptchuk, T, Klinger, R, Kelley, J

What should clinicians tell patients about placebo and nocebo effects? Practical considerations based on expert consensus by Evers, AWM, Colloca, L, Blease, C, Gaab, J, Jensen, KB, Atlas, LY, Beedie, CJ, Benedetti, F, Bingel, U, Büchel, C, Bussemaker, J, Colagiuri, B, Crum, AJ, Finniss, DG, Geers, AL, Howick, J, Klinger, R, Meeuwis, SH, Meissner, K, Napadow, V, Petrie, KJ, Rief, W, Smeets, I, Wager, TD, Wanigasekera, V, Vase, L, Kelley, JM, Kirsch, I, Consortium of Placebo Experts